Drug recall · July 5, 2023
Endometrin recall
Why: cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ NDC# 55566-6500-03
- Lots / codes
AA200A, AA201A, Exp. 12/2025
- Quantity
- N/A
- Company
- Ferring Pharmaceuticals Inc, Parsippany, NJ
- Distribution
- USA Nationwide
- Initiated
- June 12, 2023 · N/A
- Classified
- June 26, 2023
- Reported
- July 5, 2023
- Ended
- August 5, 2024
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Endometrin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.